Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

Overview of attention for article published in American Heart Journal, December 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 6 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 2 additional patents.